APA

Pignatti F., Ashby D., Brass E. P., Eichler H., Frey P., Hillege H. L., Hori A., Levitan B., Liberti L., Löfstedt R. E., McAuslane N., Micaleff A., Noel R. A., Postmus D., Renn O., Sabourin B. J., Salmonson T. & Walker S. (20160210). Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions. : Clinical pharmacology and therapeutics.

Chicago

Pignatti F, Ashby D, Brass E P, Eichler H-G, Frey P, Hillege H L, Hori A, Levitan B, Liberti L, Löfstedt R E, McAuslane N, Micaleff A, Noel R A, Postmus D, Renn O, Sabourin B J, Salmonson T and Walker S. 20160210. Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions. : Clinical pharmacology and therapeutics.

Harvard

Pignatti F., Ashby D., Brass E. P., Eichler H., Frey P., Hillege H. L., Hori A., Levitan B., Liberti L., Löfstedt R. E., McAuslane N., Micaleff A., Noel R. A., Postmus D., Renn O., Sabourin B. J., Salmonson T. and Walker S. (20160210). Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions. : Clinical pharmacology and therapeutics.

MLA

Pignatti F, Ashby D, Brass E P, Eichler H-G, Frey P, Hillege H L, Hori A, Levitan B, Liberti L, Löfstedt R E, McAuslane N, Micaleff A, Noel R A, Postmus D, Renn O, Sabourin B J, Salmonson T and Walker S. Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future Directions. : Clinical pharmacology and therapeutics. 20160210.